CombiMatrix Reiterates Previously Reported Terms of Nasdaq Listed Warrants (Symbol: CBMXW)

CombiMatrix Reiterates Previously Reported Terms of Nasdaq Listed Warrants
(Symbol: CBMXW)

IRVINE, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Due to recent trading
activity in CombiMatrix Corporation's (Nasdaq:CBMX) publicly listed warrants,
symbol CBMXW, the Company would like to reiterate the terms of said warrants.


These warrants, originally issued in April 2009 and as adjusted pursuant to
their terms by the reverse split of the Company's common stock and warrants
previously announced on December 4, 2012, currently have an exercise price of
$90.00 and will expire on May 1, 2014 if not exercised by such time.

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and
comprehensive clinical support for the highest quality of care – specializing
in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix offers
comprehensive testing services for the detection of abnormalities of genes at
the DNA level beyond what can be identified through traditional
technologies.The Company performs genetic testing utilizing microarray, FISH,
PCR and G-Band chromosome analyses. Additional information about CombiMatrix
is available at www.combimatrix.com or by calling 1-800-710-0624.

CONTACT: Company Contact:
         Mark McDonough
         President & CEO, CombiMatrix Corporation
         Tel (949) 753-0624
        
         Investor Relations / Media Contact:
         Rene Caron
         Partner
         Allen & Caron, Inc.
         Tel (949) 474-4300
         rene@allencaron.com

CombiMatrix Corporation
 
Press spacebar to pause and continue. Press esc to stop.